The rising global incidence of kidney failure has increased the demand for long-term hemodialysis, which requires reliable vascular access. While arteriovenous fistulas (AVFs) are typically preferred, alternative approaches are needed when autogenous options are exhausted. The use of translocated autologous saphenous vein (SV) conduits has been predominantly documented in developed countries but rarely employed in developing nations, including Vietnam. We presented the case of a 54-year-old patient with dysfunction of all common vascular access sites and central venous catheters. This case represents the first successful use of a translocated autologous great saphenous vein to create arteriovenous access in Vietnam, with a follow-up period of 3 years. The study also highlights the potential of autologous SV conduits as a superior option for vascular access compared to prosthetic grafts. This approach is particularly crucial in developing countries, where economic constraints and the high prevalence of kidney disease often limit access to prosthetic grafts.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1177/11297298251321516 | DOI Listing |
J Vasc Access
March 2025
Department of Vascular Surgery, Duc Tin Clinic, Ho Chi Minh, Vietnam.
The rising global incidence of kidney failure has increased the demand for long-term hemodialysis, which requires reliable vascular access. While arteriovenous fistulas (AVFs) are typically preferred, alternative approaches are needed when autogenous options are exhausted. The use of translocated autologous saphenous vein (SV) conduits has been predominantly documented in developed countries but rarely employed in developing nations, including Vietnam.
View Article and Find Full Text PDFBr J Pharmacol
March 2025
Department of Neurosurgery, Jiangnan University Medical Center, Wuxi, China.
Background And Purpose: Subarachnoid haemorrhage (SAH) is an uncommon and severe subtype of stroke, but the availability of drugs for its treatment is limited. Enhanced autophagy is believed to attenuate SAH pathology; however, autophagy level is tentatively up-regulated and then down-regulated after SAH onset in mice. Clemastine, a first-generation histamine H1R antagonist, is believed to persistently enhance autophagy.
View Article and Find Full Text PDFJ Assoc Genet Technol
January 2025
Stony Brook University Hospital, Stony Brook, NY 11794.
IgD myeloma is a rare subset of multiple myeloma characterized by the production of monoclonal IgD protein. This subset of myeloma generally has a more severe and aggressive clinical course. The case reported here is of a 61-year-old female with recurrent disease complicated by encephalopathy, myalgia, and extensive skeletal involvement.
View Article and Find Full Text PDFCurr Oncol
January 2025
Division of Hematology, Department of Internal Medicine, Faculty of Medicine, University of Debrecen, 4032 Debrecen, Hungary.
: A total of 50% of patients with AL amyloidosis have t(11;14) translocation, allowing us to use the selective oral BCL-2 inhibitor venetoclax in their treatment. : Our patient was admitted to the gastroenterology department due to weight loss and abdominal pain. An abdominal CT scan revealed some enlarged lymph nodes; therefore, he was referred to the hematology department.
View Article and Find Full Text PDFJCO Oncol Pract
January 2025
Fred Hutchinson Cancer Center, Seattle, WA.
Multiple myeloma (MM), the second most common hematologic malignancy in the United States, is characterized by repeated cycles of remission and relapse, with increasing resistance to treatment after each line of therapy. Despite the virtually incurable nature of MM, recent therapeutic breakthroughs have fundamentally reshaped its treatment landscape. This review explores evolving care paradigms, spanning from newly diagnosed MM to relapsed or refractory disease.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!